Umbilical cord blood-derived therapy for preterm lung injury: a systematic review and meta-analysis

医学 支气管肺发育不良 荟萃分析 严格标准化平均差 内科学 临床试验 脐带 相对风险 置信区间 肿瘤科 胎龄 怀孕 免疫学 生物 遗传学
作者
Elisha Purcell,Jainam Shah,Cameron J. Powell,Timothy Nguyen,Lindsay Zhou,Courtney McDonald,Beth J. Allison,Atul Malhotra
出处
期刊:Stem Cells Translational Medicine [Wiley]
卷期号:13 (7): 606-624
标识
DOI:10.1093/stcltm/szae033
摘要

Abstract Introduction Lung injuries, such as bronchopulmonary dysplasia (BPD), remain a major complication of preterm birth, with limited therapeutic options. One potential emerging therapy is umbilical cord blood (UCB)-derived therapy. Objectives To systematically assess the safety and efficacy of UCB-derived therapy for preterm lung injury in preclinical and clinical studies. Methods A systematic search of MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, and WHO International Trials Registry Platform was performed. A meta-analysis was conducted with Review Manager (5.4.1) using a random effects model. Data was expressed as standardized mean difference (SMD) for preclinical data and pooled relative risk (RR) for clinical data, with 95% confidence intervals (CI). Potential effect modifiers were investigated via subgroup analysis. Certainty of evidence was assessed using the GRADE system. Results Twenty-three preclinical studies and six clinical studies met eligibility criteria. Statistically significant improvements were seen across several preclinical outcomes, including alveolarization (SMD, 1.32, 95%CI [0.99, 1.65]), angiogenesis (SMD, 1.53, 95%CI [0.87, 2.18]), and anti-inflammatory cytokines (SMD, 1.68, 95%CI [1.03, 2.34]). In clinical studies, 103 preterm infants have received UCB-derived therapy for preterm lung injury and no significant difference was observed in the development of BPD (RR, 0.93, 95%CI [0.73, 1.18]). Across both preclinical and clinical studies, administration of UCB-derived therapy appeared safe. Certainty of evidence was assessed as “low.” Conclusions Administration of UCB-derived therapy was associated with statistically significant improvements across several lung injury markers in preclinical studies. Early clinical studies demonstrated the administration of UCB-derived therapy as safe and feasible but lacked data regarding efficacy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
芸茹的雪琉璃完成签到 ,获得积分10
刚刚
刚刚
369ninja发布了新的文献求助10
刚刚
研友_8RyzBZ发布了新的文献求助10
4秒前
liu完成签到 ,获得积分10
5秒前
Albert完成签到,获得积分10
7秒前
求知小生完成签到 ,获得积分0
12秒前
Luna完成签到 ,获得积分10
17秒前
yhjyhjyhj完成签到 ,获得积分10
19秒前
风趣朝雪完成签到,获得积分10
20秒前
tengo完成签到,获得积分10
20秒前
阿晏完成签到 ,获得积分10
21秒前
粗暴的导师完成签到,获得积分10
21秒前
如泣草芥发布了新的文献求助10
23秒前
小g完成签到 ,获得积分10
24秒前
李爱国的应助被leb采纳,获得10
25秒前
小鱼崽完成签到 ,获得积分10
26秒前
27秒前
Richard完成签到 ,获得积分10
28秒前
kk完成签到,获得积分10
28秒前
Psychexin发布了新的文献求助10
32秒前
关中王完成签到 ,获得积分10
33秒前
鲁卓林完成签到,获得积分10
33秒前
苹果松完成签到,获得积分10
36秒前
CipherSage的应助被奋斗的石头采纳,获得30
36秒前
乐乐的应助被研友_8RyzBZ采纳,获得10
40秒前
Perrylin718完成签到,获得积分10
41秒前
Psychexin完成签到,获得积分10
42秒前
吉吉完成签到,获得积分10
44秒前
Farer完成签到 ,获得积分10
44秒前
zq完成签到 ,获得积分10
45秒前
49秒前
凡凡完成签到,获得积分10
49秒前
泡芙小姐完成签到 ,获得积分10
51秒前
小哈完成签到 ,获得积分10
51秒前
姜颜完成签到 ,获得积分10
53秒前
研友_8RyzBZ发布了新的文献求助10
53秒前
金鱼完成签到 ,获得积分10
55秒前
风趣的月光完成签到 ,获得积分10
56秒前
VVA发布了新的文献求助30
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159073
求助须知:如何正确求助?哪些是违规求助? 9554564
关于积分的说明 21719582
捐赠科研通 7748705
什么是DOI,文献DOI怎么找? 3427139
关于科研通互助平台的介绍 2552054
邀请新用户注册赠送积分活动 2471416